The CAS Star-backed round looks set to be the last for the satellite imaging technology producer before a planned initial public offering.

The anti-malware software provider's series E round has valued the UC Berkeley spinout at $800m.

The fitness and sleep tracker provider, an alumnus of Harvard Innovation Lab, was valued at $1.2bn in a round that took its total funding past $200m.

Sarepta Therapeutics provided $15m in a series A round for the company, which is advancing University of Florida research.

Oxford Nanopore has continued its funding streak with another $108m, bringing this year's haul to more than $208m and its overall total to around $800m.

Group 42 and BP Ventures have co-led a series C round for Caltech and Nasa spinout Beyond Limits, with $113m already closed.

SR One, AbbVie Ventures, Takeda Ventures and Pfizer Ventures all returned for the cancer and inflammatory disease drug developer's series B.

Syncona, Jeito Capital and EcoR1 Capital have co-led the Netherlands Cancer Institute-founded Neogene Therapeutics' series A round.

University of Utah's drug discovery technology producer has raised series D funding to increase its post-money valuation to some $1.2bn.

ETH Zurich-founded carbon capture system producer Climeworks has added $35m to its latest round to fund further business growth.